학술논문
Discontinuation of disease modifying treatments in middle aged multiple sclerosis patients. First line drugs vs natalizumab
Document Type
Article
Source
In Multiple Sclerosis and Related Disorders February 2017 12:82-87
Subject
Language
ISSN
2211-0348